Name Net reduced
positions
Reduced positions Increased positions Return since
31 Mar ‘20
426
2 5 3 38.3%
427
2 2 0 405%
428
2 10 8 70.6%
VRCA icon
429
Verrica Pharmaceuticals
VRCA
$84.9M
2 17 15 95.1%
430
2 2 0 116%
431
2 11 9 12.9%
432
2 10 8 61.2%
433
2 2 0 44.7%
434
2 2 0 77.3%
435
2 2 0 99.7%
UPGD icon
436
Invesco Bloomberg Analyst Rating Improvers ETF
UPGD
$106M
2 8 6 168%
437
2 2 0 100%
438
2 3 1 47.4%
439
2 6 4 81.9%
440
2 5 3 16.1%
441
2 3 1 88.6%
442
2 6 4 39.6%
443
2 2 0 38.4%
444
2 2 0 67.4%
445
1 15 14 51.9%
446
1 3 2 37.6%
447
1 3 2 143%
448
1 1 0 152%
449
1 1 0 141%
450
1 7 6 99.9%